ArticleUnited European gastroenterology journal2019
Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug.
Article in United European gastroenterology journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases.Chinese medical journal · 2022Pooled it
- Science of fecal microbiota transplant: From history to cutting-edge clinical practice.World journal of gastrointestinal endoscopy · 2026Review
- Addressing Unmet Needs inCurrent medicinal chemistry · 2026Review
- Fecal microbiota transplantation: a tale of two regulatory pathways.Gut microbes · 2025Review
- The Regulatory Approach for Faecal Microbiota Transplantation as Treatment forAntibiotics (Basel, Switzerland) · 2022Article
- Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients.Journal of clinical microbiology · 2022Review
- Stools' donor recruitment, a challenge in pandemic times.United European gastroenterology journal · 2021Article
- The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey.The Lancet regional health. Europe · 2021Article
- Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21World journal of gastroenterology · 2021Article
- Faecal microbiota transplants: Why do we not consider them as Advanced Therapy Medicinal Products?United European gastroenterology journal · 2021Article
- A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group.United European gastroenterology journal · 2021Article
- Regulation, risk and safety of Faecal Microbiota Transplant.Infection prevention in practice · 2020Review
- Towards an EU-wide suitable regulatory framework for faecally derived, industrially manufactured medicinal products.United European gastroenterology journal · 2020Article
Corrections and comments
- Commented on by
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.